Mitchell S. Stark

Country flagAustralia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Background Actinic keratoses (AK) are pre‐malignant skin lesions caused by chronic sun exposure. Progression from an AK to intraepidermal carcinoma (IEC) and a cutaneous squamous cell carcinoma (SCC) is well known but the rate of transformation to an invasive SCC is highly variable. Since no definitive biomarkers are available, treatment decisions are made ad hoc. Objectives To fully characterise our AK to SCC progression series, we performed microRNA (miRNA) microarray expression profiling of normal and photodamaged skin, as well as AKs, IEC, and invasive SCCs. Methods The study recruited 27 patients who donated fresh biopsies of normal skin, photodamaged skin, AK, IEC, and SCC ( n = 67 specimens). All miRbase (v.21) miRNAs were profiled to identify miRNAs related to SCC progression. miRNAs were validated using qRT‐PCR and in vitro phenotypic assays. Results There were 234 robustly expressed miRNAs across the tissue collection, which resulted in 20 miRNA that were differentially expressed ((cor) p ≤ 0.05 and ≥ 10 fold) between normal skin and SCC. Hierarchical clustering all samples illustrated that AKs, IEC, and SCCs were largely indistinguishable, which confirms the premalignant status of an AK. A panel of miRNAs showed significant dysregulation between normal and photodamaged skin and AK. Importantly, we found miR‐34a‐5p and miR‐31‐5p had significant differential expression between AKs and IEC and IEC and SCC respectively. Phenotypic assays determined that the miR‐31 duplex had opposing effects on SCC cell lines which suggests that dysregulation of this duplex may be related to the dynamic control of progression of transformed keratinocytes. Conclusions This study confirmed the continuum of AK with IEC and SCC highlighting that miRNA expression plays a role in keratinocyte transformation. Development of our putative miRNA biomarker candidates is warranted to aid in clinical management of patients experiencing high AK load to determine the most appropriate treatment.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Katie Lee

The University of Queensland

AUSTRALIA
View details

Monika Janda

Professor in Behavioural Science

University of Queensland

AUSTRALIA
View details

Xiaoqiong Qi

University of Queensland

AUSTRALIA
View details

Michael Brunig

University of Queensland

AUSTRALIA
View details

H. Peter Soyer

The University of Queensland Diamantina Institute

AUSTRALIA
View details

Dragan Indjin

Reader in Optoelectronics and Nanoscale Electronics/Deputy Director of Student Education

University of Leeds

UNITED KINGDOM
View details

Brigid Betz-Stablein

University of Queensland

AUSTRALIA
View details

Matt Trau

-

AUSTRALIA
View details

Karl Bertling

Senior Lecturer

University of Queensland

AUSTRALIA
View details

Aleksandar D. Rakić

University of Queensland

AUSTRALIA
View details

Douglas Grossman

Professor

University of Utah Health Sciences Center

UNITED STATES
View details

Robert Judson‐Torres

-

UNITED STATES
View details

Courtney Wallingford

The University of Queensland

AUSTRALIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.